Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain-Reference-Cited by-同舟云学术

Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain

Published:2012-04 Issue:8 Volume:22 Page:2932-2937
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Adam Julia M.,Clark John K.,Davies Keneth,Everett Kathryn,Fields Ruth,Francis Stuart,Jeremiah Fiona,Kiyoi Takao,Maidment Maurice,Morrison Angus,Ratcliffe Paul,Prosser Alan,Schulz Jurgen,Wishart Grant,Baker James,Boyce Susan,Campbell Robert,Cottney Jean E.,Deehan Maureen,Martin Iain

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference39 articles.

1. Targeting cannabinoid agonists for inflammatory and neuropathic pain

2. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

3. CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS

4. Using cannabinoids in pain and palliative care

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoids, the endocannabinoid system, and pain;Pain;2021-03-15

2. Cannabinoids in the Treatment of Back Pain;Neurosurgery;2020-02-25

3. Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain;International Journal of Molecular Sciences;2020-02-20

4. Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain;MedChemComm;2019

5. Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation;Neuropharmacology;2018-09